Amyloid Neuropathies, Familial
"Amyloid Neuropathies, Familial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inherited disorders of the peripheral nervous system associated with the deposition of AMYLOID in nerve tissue. The different clinical types based on symptoms correspond to the presence of a variety of mutations in several different proteins including transthyretin (PREALBUMIN); APOLIPOPROTEIN A-I; and GELSOLIN.
| Descriptor ID |
D028227
|
| MeSH Number(s) |
C10.574.500.050 C10.668.829.050.050 C16.320.400.050 C16.320.565.176.050 C18.452.648.176.050 C18.452.845.500.050.050 C18.452.845.500.075.050
|
| Concept/Terms |
Amyloid Neuropathies, Familial- Amyloid Neuropathies, Familial
- Amyloid Neuropathy, Familial
- Familial Amyloid Neuropathies
- Familial Amyloid Neuropathy
- Neuropathies, Familial Amyloid
- Neuropathy, Familial Amyloid
- Hereditary Neuropathic Amyloidosis
- Amyloidoses, Hereditary Neuropathic
- Amyloidosis, Hereditary Neuropathic
- Hereditary Neuropathic Amyloidoses
- Neuropathic Amyloidoses, Hereditary
- Neuropathic Amyloidosis, Hereditary
- Familial Amyloid Polyneuropathies
- Amyloid Polyneuropathies, Familial
- Amyloid Polyneuropathy, Familial
- Familial Amyloid Polyneuropathy
- Polyneuropathies, Familial Amyloid
- Polyneuropathy, Familial Amyloid
Amyloid Polyneuropathy, British Type- Amyloid Polyneuropathy, British Type
- Type III Familial Amyloid Polyneuropathy
- Familial Amyloid Polyneuropathy, Type III
- Iowa Type Amyloid Polyneuropathy
- Amyloid Polyneuropathy, Iowa Type
- British Type Amyloid Polyneuropathy
Familial Amyloid Neuropathy, Portuguese Type- Familial Amyloid Neuropathy, Portuguese Type
- Familial Amyloid Neuropathy, Andrade Type
- Familial Amyloid Polyneuropathy, Type I
- Familial Portuguese Polyneuritic Amyloidosis
- Wohlwill-Corino Andrade Syndrome
- Syndrome, Wohlwill-Corino Andrade
- Wohlwill Corino Andrade Syndrome
- Polyneuritic Amyloidosis, Portuguese
- Amyloidoses, Portuguese Polyneuritic
- Amyloidosis, Portuguese Polyneuritic
- Polyneuritic Amyloidoses, Portuguese
- Portuguese Polyneuritic Amyloidoses
- Portuguese Polyneuritic Amyloidosis
- Portuguese Type Familial Amyloid Neuropathy
- Type I Familial Amyloid Polyneuropathy
- Wohlwill-Andrade Syndrome
- Syndrome, Wohlwill-Andrade
- Wohlwill Andrade Syndrome
- Amyloid Neuropathy Type 1
- Neuropathic Amyloid Syndrome
- Amyloid Syndrome, Neuropathic
- Amyloid Syndromes, Neuropathic
- Neuropathic Amyloid Syndromes
- Syndrome, Neuropathic Amyloid
- Syndromes, Neuropathic Amyloid
Familial Amyloid Polyneuropathy, Type V- Familial Amyloid Polyneuropathy, Type V
- Finnish Type Familial Amyloid Neuropathy
- Type V Familial Amyloid Polyneuropathy
- Familial Amyloid Neuropathy, Finnish Type
Amyloid Polyneuropathy, Swiss Type- Amyloid Polyneuropathy, Swiss Type
- Swiss Type Amyloid Polyneuropathy
- Type II Familial Amyloid Polyneuropathy
- Familial Amyloid Polyneuropathy, Type II
|
Below are MeSH descriptors whose meaning is more general than "Amyloid Neuropathies, Familial".
- Diseases [C]
- Nervous System Diseases [C10]
- Neurodegenerative Diseases [C10.574]
- Heredodegenerative Disorders, Nervous System [C10.574.500]
- Amyloid Neuropathies, Familial [C10.574.500.050]
- Neuromuscular Diseases [C10.668]
- Peripheral Nervous System Diseases [C10.668.829]
- Amyloid Neuropathies [C10.668.829.050]
- Amyloid Neuropathies, Familial [C10.668.829.050.050]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Heredodegenerative Disorders, Nervous System [C16.320.400]
- Amyloid Neuropathies, Familial [C16.320.400.050]
- Metabolism, Inborn Errors [C16.320.565]
- Amyloidosis, Familial [C16.320.565.176]
- Amyloid Neuropathies, Familial [C16.320.565.176.050]
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Metabolism, Inborn Errors [C18.452.648]
- Amyloidosis, Familial [C18.452.648.176]
- Amyloid Neuropathies, Familial [C18.452.648.176.050]
- Proteostasis Deficiencies [C18.452.845]
- Amyloidosis [C18.452.845.500]
- Amyloid Neuropathies [C18.452.845.500.050]
- Amyloid Neuropathies, Familial [C18.452.845.500.050.050]
- Amyloidosis, Familial [C18.452.845.500.075]
- Amyloid Neuropathies, Familial [C18.452.845.500.075.050]
Below are MeSH descriptors whose meaning is more specific than "Amyloid Neuropathies, Familial".
This graph shows the total number of publications written about "Amyloid Neuropathies, Familial" by people in this website by year, and whether "Amyloid Neuropathies, Familial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 2 | 0 | 2 |
| 2022 | 4 | 0 | 4 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 1 | 2 |
| 2025 | 3 | 1 | 4 |
| 2026 | 4 | 2 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amyloid Neuropathies, Familial" by people in Profiles.
-
Clinical features of systemic amyloidosis: a scoping review. Blood Adv. 2026 Jul 28; 10(14):5097-5112.
-
Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection. Circ Cardiovasc Imaging. 2026 Jun; 19(6):e019610.
-
Acoramidis, Serum Transthyretin, and Cardiovascular Outcomes in Transthyretin Amyloid Cardiomyopathy: Insights From the ATTRibute-CM Trial. J Card Fail. 2026 May; 32(5):864-876.
-
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy: Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial. JAMA Cardiol. 2026 May 01; 11(5):446-454.
-
Acoramidis in transthyretin amyloid cardiomyopathy: expanding evidence from ATTRibute-CM. Future Cardiol. 2026 02; 22(2):119-133.
-
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy: Results From ATTRibute-CM and Its Open-Label Extension. JAMA Cardiol. 2026 Jan 01; 11(1):57-67.
-
Coramitug, a Humanized Monoclonal Antibody for the Treatment of Transthyretin Amyloid Cardiomyopathy: A Phase 2, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial. Circulation. 2026 Jan 27; 153(4):214-225.
-
Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool. Eur Heart J. 2025 10 22; 46(40):4090-4101.
-
Disparities in diagnosis and outcomes in American patients with transthyretin cardiac amyloidosis. Int J Cardiovasc Imaging. 2025 Aug; 41(8):1487-1496.
-
Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy. J Am Coll Cardiol. 2025 May 27; 85(20):1911-1923.